Search research articles
Contact Us
Filters
Showing results (51-60 of 139) with videos related to
Page
of 14
Sort By:
Oral Oncology
|
February 19, 2013
Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: review of the literature and proposal for management changes
Frédéric Peyrade, Didier Cupissol, Lionel Geoffrois, et al.
International Journal of Oncology
|
July 16, 2002
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells
Eric Raymond, Christophe Louvet, Christophe Tournigand, et al.
Cancer Chemotherapy and Pharmacology
|
October 4, 2007
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
Nasredine Aissat, Christophe Le Tourneau, Aïda Ghoul, et al.
Oncotarget
|
January 8, 2014
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
Cindy Neuzillet, Armand de Gramont, Annemilaï Tijeras-Raballand, et al.
Seminars in Oncology
|
August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C family
Maria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Oral Oncology
|
November 7, 2017
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Petr Szturz, Marie Budíková, Jan B Vermorken, et al.
Annals of Surgical Oncology
|
August 13, 2011
Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis
Cédric Rau, Benjamin Blanc, Maxime Ronot, et al.
Annals of Surgery
|
October 26, 2012
Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases
François Cauchy, Béatrice Aussilhou, Safi Dokmak, et al.
Targeted Oncology
|
August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
Annemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 139) with videos related to
Sort By:
Page
of 14
Oral Oncology
|
February 19, 2013
Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: review of the literature and proposal for management changes
Frédéric Peyrade, Didier Cupissol, Lionel Geoffrois, et al.
International Journal of Oncology
|
July 16, 2002
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells
Eric Raymond, Christophe Louvet, Christophe Tournigand, et al.
Cancer Chemotherapy and Pharmacology
|
October 4, 2007
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines
Nasredine Aissat, Christophe Le Tourneau, Aïda Ghoul, et al.
Oncotarget
|
January 8, 2014
Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas
Cindy Neuzillet, Armand de Gramont, Annemilaï Tijeras-Raballand, et al.
Seminars in Oncology
|
August 8, 2006
Preclinical and clinical development of novel agents that target the protein kinase C family
Maria Serova, Aïda Ghoul, Karim A Benhadji, et al.
Oral Oncology
|
November 7, 2017
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Petr Szturz, Marie Budíková, Jan B Vermorken, et al.
Annals of Surgical Oncology
|
August 13, 2011
Neither preoperative computed tomography nor intra-operative examination can predict metastatic lymph node in the hepatic pedicle in patients with colorectal liver metastasis
Cédric Rau, Benjamin Blanc, Maxime Ronot, et al.
Annals of Surgery
|
October 26, 2012
Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases
François Cauchy, Béatrice Aussilhou, Safi Dokmak, et al.
Targeted Oncology
|
August 28, 2012
Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies
Annemilaï Tijeras-Raballand, Cindy Neuzillet, Anne Couvelard, et al.
Cancer Treatment Reviews
|
August 20, 2013
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
Page
of 14